Literature DB >> 12907677

Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).

Viktor M Paromov1, Richard E Morton.   

Abstract

Cholesterol ester transfer protein (CETP) moves triglyceride (TG) and cholesteryl ester (CE) between lipoproteins. CETP has no apparent preference for high (HDL) or low (LDL) density lipoprotein as lipid donor to very low density lipoprotein (VLDL), and the preference for HDL observed in plasma is due to suppression of LDL transfers by lipid transfer inhibitor protein (LTIP). Given the heterogeneity of HDL, and a demonstrated ability of HDL subfractions to bind LTIP, we examined whether LTIP might also control CETP-facilitated lipid flux among HDL subfractions. CETP-mediated CE transfers from [3H]CE VLDL to various lipoproteins, combined on an equal phospholipid basis, ranged 2-fold and followed the order: HDL3 > LDL > HDL2. LTIP inhibited VLDL to HDL2 transfer at one-half the rate of VLDL to LDL. In contrast, VLDL to HDL3 transfer was stimulated, resulting in a CETP preference for HDL3 that was 3-fold greater than that for LDL or HDL2. Long-term mass transfer experiments confirmed these findings and further established that the previously observed stimulation of CETP activity on HDL by LTIP is due solely to its stimulation of transfer activity on HDL3. TG enrichment of HDL2, which occurs during the HDL cycle, inhibited CETP activity by approximately 2-fold and LTIP activity was blocked almost completely. This suggests that LTIP keeps lipid transfer activity on HDL2 low and constant regardless of its TG enrichment status. Overall, these results show that LTIP tailors CETP-mediated remodeling of HDL3 and HDL2 particles in subclass-specific ways, strongly implicating LTIP as a regulator of HDL metabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907677     DOI: 10.1074/jbc.M306580200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

2.  Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.

Authors:  Catherine N Vu; Raul Ruiz-Esponda; Eric Yang; Evelyn Chang; Baiba Gillard; Henry J Pownall; Ron C Hoogeveen; Ivonne Coraza; Ashok Balasubramanyam
Journal:  Metabolism       Date:  2013-03-19       Impact factor: 8.694

3.  Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.

Authors:  Eric J Niesor; Christine Magg; Naoto Ogawa; Hiroshi Okamoto; Elisabeth von der Mark; Hugues Matile; Georg Schmid; Roger G Clerc; Evelyne Chaput; Denise Blum-Kaelin; Walter Huber; Ralf Thoma; Philippe Pflieger; Makoto Kakutani; Daisuke Takahashi; Gregor Dernick; Cyrille Maugeais
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

4.  Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons.

Authors:  David L Rainwater; Laura A Cox; Jeffrey Rogers; John L VandeBerg; Michael C Mahaney
Journal:  J Lipid Res       Date:  2009-03-08       Impact factor: 5.922

5.  Combined statin and niacin therapy remodels the high-density lipoprotein proteome.

Authors:  Pattie S Green; Tomas Vaisar; Subramaniam Pennathur; J Jacob Kulstad; Andrew B Moore; Santica Marcovina; John Brunzell; Robert H Knopp; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

6.  Identification of candidate genes encoding an LDL-C QTL in baboons.

Authors:  Genesio M Karere; Jeremy P Glenn; Shifra Birnbaum; Sassan Hafizi; David L Rainwater; Michael C Mahaney; John L VandeBerg; Laura A Cox
Journal:  J Lipid Res       Date:  2013-04-17       Impact factor: 5.922

7.  Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.

Authors:  Yubin He; Diane J Greene; Michael Kinter; Richard E Morton
Journal:  J Lipid Res       Date:  2008-03-27       Impact factor: 5.922

8.  Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.

Authors:  Arundhati Undurti; Ying Huang; Joseph A Lupica; Jonathan D Smith; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

9.  Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia.

Authors:  Lahoucine Izem; Richard E Morton
Journal:  J Lipid Res       Date:  2008-11-13       Impact factor: 5.922

10.  Effect of compounds affecting ABCA1 expression and CETP activity on the HDL pathway involved in intestinal absorption of lutein and zeaxanthin.

Authors:  Eric J Niesor; Evelyne Chaput; Jean-Luc Mary; Andreas Staempfli; Andreas Topp; Andrea Stauffer; Haiyan Wang; Alexandre Durrwell
Journal:  Lipids       Date:  2014-10-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.